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Valorisation 
 
 
By exploring the experiences and perspectives of people from sub-Saharan African countries involved 
with clinical trials, as well as the context in which these activities take place, my dissertation provides 
analysis and insight into the ways certain people engage and construct meaning around clinical trials 
and participation. To provide this knowledge I studied interventional clinical trials and the local 
participation of citizens in trial settings from Ghana and across Tanzania. As demonstrated in the 
previous chapters of this of this book, I used this information to highlight the potential impact 
perceptions and approaches to participation can have in developing more sustainable and mutually 
beneficial research frameworks, policies and practices. Thus, this can help further contribute to creating 
a bridge between the different perspectives and approaches that have resulted in tensions arising between 
global clinical trial processes and the local involvement of trial participants.  
 
 
Value for innovation in clinical trials 
 
Dynamic engagement - the involved participant 
 
The work done in this thesis mainly focuses on participant voices from lower resourced settings and 
their perceptions of clinical trial involvement. The people involved in my research span from highly 
educated university students to farmers having little to no formal education, all providing important 
ideas about what it means for them to be involved in trials and what trials come to represent for them. 
Thus the findings arising from these insights makes the work that I present in this thesis valuable for 
providing a broader understanding of local concerns, expectations, and tensions embedded in alternative 
points of view, for research ethics committees who are tasked with determining the scientific merit of 
research and ensuring that the rights of research participants are observed and respected. As my work 
demonstrates, the perspectives held by participants about trials and the processes that guide them are not 
always in line with those actors charged with conducting and overseeing research. Often it seemed as 
though the answer to dealing with these alternative perspectives was to provide more knowledge and 
education to participants to converge any potentially misaligned ideas. However, such an approach 
reinforces the idea of hierarchy and dismisses the relevance of local voices. Instead, my work supports 
the need for continuous engagement with local voices, and for all stakeholders – with the inclusion of 
trial participants – to work together over the course of the trial to develop practices and frameworks that 
in turn would be of greater overall benefit to those supporting research through participation in lower 
resourced settings; whether through improved information sharing, resource distribution, or the general 
improvement of clinical trial quality and the development of useful interventions needed in the local 
communities.  
 Additionally, the work that I have conducted in this thesis highlights the need for clinical trials to 
take on a more reflexive and inclusive approach to trial participation, particularly in settings where trial 
research conduct has not been well-established yet. While it is not uncommon for there to be separation 
between members of research ethics committees, researchers and participants, the work that I have done 
points to a desire for more dynamic engagement in research. Rather than being passive trial participants, 
what is seen is a desire to be made a part of what is happening with trials and trial outcomes, whether 
this is debriefing and the conclusion of a trials, or the ability of participants, researches, and ethical 
committee members to engage and discuss during the course of the trial. In my analysis I have shown 
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that this is informally already taking place during scheduled appointments, in the trial waiting rooms, or 
during unscheduled visits to the research centres by participants who feel fully invested in the outcome 
of research. My work shows the potential benefit of providing a more formal mechanism through which 
this process can happen; leading to tensions being worked out before they become irreversibly 
problematic, misaligned perspectives on issues such as what constitutes risks and benefits becoming an 
ongoing discussion rather than fixed concepts, and relatedly, the job of ethics committee members being 
seen as continuous throughout the course of the trial, instead of essentially concluding before the actual 
commencement of the trial.   
 
 
Context as an active element of participation 
 
Furthermore, there is great value provided by this research, in that it looks at participation, decision-
making and trial conduct in relation to context. The framework which governs international clinical 
trials, including the following of international guidelines like CIOMS, and the Helsinki declaration 
underscores a connection between the context in which trials take place and the safety, benefit and 
welfare of participants in trials. The added value my work brings is that it provides deeper insight into 
how exactly context plays a role in developing understandings, perspectives and decision-making by 
participants who are involved with trials in lower resourced settings. This information is valuable for 
both sponsors of research who intend to do work in such settings and research ethics committee 
members, and institutional review boards who are trying to assess the impact of trials on participants 
and the local community. This research provides more information as to how context may or may not 
influence vulnerability of potential research participants, how context is involved in the development of 
perspectives in lower resourced settings, and the impact this has on participant decision-making. The 
focus of this research centred on lower resourced trial participation in sub-Saharan Africa. However, the 
lessons provided by it also serve as reflection points from which participation of individuals from lower 
resourced communities across the globe, including in higher income countries, may also be explored 
and strategies for improved trial involvement developed.  
 
Valorisation in Practice 
 
One way in which this research attains value is through its dissemination in the form of published 
scholarship, to those who would benefit from its results. This includes not only researchers, sponsors, 
academics, and members of institutional review boards and research ethics committees, but participants 
themselves, who have explicitly requested to receive the findings of the work I conducted. As such, the 
empirical chapters of this book have been either published or prepared for publication in academic 
journals (see publication list for overview of texts).  
However, publications are only one way in which research results and insights can be shared. Over the 
course of my research I have also used conferences and workshops as a platform in which to share my 
findings and actively engage in discussion about the impact and potential value of my work. I have 
presented and discussed my work in several relevant events: 
 
Relevant conferences:  
- FOREIGN BODIES IN CONVERSATION: a public symposium for those researching 
global health. The Jan Van Eyck Academie (2017), I organized this conference to bring 
together actors in health that normally would not get to come together in such an 
environment to discuss clinical trials from various discipline perspectives 
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- Revealing discourses: (re)imagining innovation and governance through international 
clinical trials, EASST/4S Conference Science & technology by other means: Exploring 
collectives, spaces and futures, Barcelona, Spain (2016) 
 
- “Dreaming of Health and Science in Africa: Aesthetics, Affects, Poetics and Politics” 
conference (2015)  https://africanbiosciences.wordpress.com/events/dreamingscience 
- “Oxford Global Health Bioethics International Conference” (2015) 
http://www.ndph.ox.ac.uk/upcoming-events/global-health-ethics 
 
- “International conference Social Sciences and Medical Innovations” (2014), where I spoke 
about and shared my findings on the meaning giving to trial participation by Ghanaian 
citizens 
 
 
 
Relevant workshops/meetings:  
 
- workshop on Ethical Review in Global Health (2018) hosted by Amsterdam public health 
consortium  
- NIMR Mwanza Research Centre (MRC) clinical trials meeting (2015), where I participated 
and engaged with government officials, international trial sponsors, research staff and 
industry representatives sharing the results of my findings  
 
- (Invited talk) International biomedical research: science, society, and pharmaceutical 
innovation & development, Center for Bioethics and Social Sciences in Medicine seminar, 
Michigan, USA (2015), spoke to various medical, health and educational staff with a vested 
interest in clinical trials and participation about my work 
  
